Publications
- Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic2024 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine
- Risk factors for comorbidities in Czech psoriatic patients: Results of a hospital-based case-control study2014 | Second Faculty of Medicine
- Our Experience with Ustekinumab for the Treatment of Psoriasis2011 | Second Faculty of Medicine
- Serious type psoriasis with a significant mental disability treated efalizumabem2008 | Second Faculty of Medicine
- Atopic Dermatitis: Current Recommendations for Diagnosis and Treatment. Part I2023 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- BIOREP - Biologic/Targeted Therapy Registry: 2022 Summary Report2023 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Atopic Dermatitis: Current Guidelines for Diagnosis and Treatment. Part II2023 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine
- Employing Adalimumab in Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Real-Life Multicenter Data from the Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine
- Successful treatment with adalimumab in a patient with psoriasis, acne and sacroiliitis2023 | First Faculty of Medicine
- Léčba dupilumabem u pacientky se závažnou atopickou dermatitidou doprovázenou úzkostnými stavy2023 | First Faculty of Medicine
Loading network view...